II. Indications
- Moderate to Severe Major Depression
- Consider in Mild Major Depression
III. Approach
- Combine Antidepressants with Psychotherapy for Depression
- Providers tend to under dose depression
- Refractory Depression may simply need higher levels
- Duration of therapy after remission of symptoms
- Young: 6 months minimum treatment
- Elderly: 2 years minimum use
- Rebound Depression off medication: Indefinite use
- Continued use reduces relapse risk by two thirds
- Geddes (2003) Lancet 361:653-61 [PubMed]
- Specific Population Approaches
IV. Efficacy
- Antidepressants offer Statistically SignificantMajor Depression improvement, but not all patients benefit
- Fewer than one third of patients achieve Major Depression remission with the first Antidepressant
-
Number Needed to Treat (NNT) to result in clinical response or remission
- Tricyclic Antidepressants NNT 9
- Selective Serotonin Reuptake Inhibitors (SSRI) NNT 7
- Venlafaxine NNT 6
- References
V. Adverse Effects
VI. Protocol
- Choosing an Antidepressant
- Consider Antidepressant Adverse Effects
- Consider Antidepressants that have been effective for close family members
- Consider Depression Types (see below)
- Anxious or agitated
- Inhibited or withdrawn
- Start with generic agents if possible
- Warn patients about expected side effects
- See Antidepressant Adverse Effects
- At least 60% of patients will have some adverse effects, and these effects precede the benefit by months
- Consider effect on sexual function (see below)
- Choosing a dosage
- Many patients are not on the optimal dose
- Write prescription to allow patient to increase
- Start at sub-therapeutic dose to reduce side effects
- Increase dose to minimum effective dose in 5-7 days
- Allow patient to increase dose again in 2-3 weeks
- Example: Celexa 20 mg (write for 60 with refills)
- Start at 1/2 tablet daily for 5-7 days
- Then increase to 1 pill daily for 2-3 weeks
- Then consider increase to 2 pills daily
- Many patients are not on the optimal dose
- Titrating to effective dose
- Increase dose as tolerated to optimal dose over 6 to 12 weeks
- Reevaluate at 4 to 6 weeks of optimal dose
- Consider adding a second agent if inadequate effect
- Consider switching agents if no significant improvement
-
Antidepressant Course
- Acute Phase (6 weeks to 3 months)
- Target remission of symptoms and improved function
- Continuation Phase (4 to 9 months)
- Reduce relapse rates and keep symptoms at bay
- Continuation for at least 6 months is recommended
- Maintenance Phase (10 months to >1 year)
- Reduce risk of symptom recurrence
- Continue reevaluation of Major Depression
- Consider discontinuation as risk of recurrence decreases
- Acute Phase (6 weeks to 3 months)
- Switching Antidepressants
- Balance the risk of Serotonin Syndrome with the risk of Antidepressant Withdrawal
- Risk of Serotonin Syndrome if multiple Serotonergic Medications are used at the same time
- Risk of Antidepressant Withdrawal during a gap between Antidepressants
- Cross Taper
- Slowly decrease one medication dose by 25% of maintenance dose every 4 weeks AND
- Simultaneously start and titrate the new medication dose by 25% of target dose every 4 weeks
- Direct switch
- Stop one medication (consider tapering dose by 25% every 4 weeks before stopping)
- Washout period or gap between medications
- Choose either no gap between medications, a short gap of 2-3 days or a longer gap of 7 days
- Consider longer washout periods (4-5 half-lives) with longer Half-Life medications
- Start the new medication and titrate dose slowly to target dose
- Balance the risk of Serotonin Syndrome with the risk of Antidepressant Withdrawal
-
Antidepressant Discontinuation
- Antidepressant is recommended for at least 6 months before stopping
- Risk of Antidepressant Withdrawal on stopping medication
- Decrease dose by 25% every 4 weeks or 12.5% every 2 weeks (stopping medication over 3-4 months)
- Citalopram 40 mg for 4 weeks, then 30 mg for 4 weeks, then 20 mg for 4 weeks, then 10 mg for 4 weeks...
- Review risk of relapse after medication discontinuation with patient
- Consider scheduled follow-up at 6-12 months after stopping medication
- Major Depression relapse occurrs within 1 year in >50% of patients after stopping meds after initial resolution
VII. Management: General agents
- First choice
- Escitalopram (Lexapro) or Citalopram (Celexa)
- Sertraline (Zoloft)
- Buproprion (Wellbutrin)
- Activating (consider in Fatigue, use caution in anxiety)
- Second choice (due to side effects)
- Fluoxetine (Prozac): Activating
- Paroxetine (Paxil): Sedating and withdrawal risk
- Mirtazapine (Remeron): Sedating and weight gain
- Elderly may see side effects as helpful
- May be helpful in Insomnia
- References
- Goad (2007) Chronic Disease Lecture, MPLS
VIII. Management: Agitation or Insomnia
- Use Sedating Antidepressant
- Paroxetine (Paxil)
- Mirtazapine (Remeron)
- Also useful in stimulating appetite, but risk of increased weight gain
- Consider medication to assist sleep
- Consider Benzodiazepine for first 1-2 weeks (Exercise caution)
IX. Management: Anxiety
X. Management: Pain
XI. Management: Psychotic Depression
XII. Management: Inhibited Depression
- First Line: SSRI
- Second Line: Tricyclic Antidepressant
XIII. Management: Sexual Dysfunction
- See Antidepressant Induced Sexual Dysfunction
- Man with Premature Ejaculation: Paxil
- Woman lacks orgasm: Buspar 30 minutes prior to sex
- Agents least likely to affect sexual function
XIV. Management: Perimenopausal Major Depression
XV. Management: Depression Refractory to Antidepressants
XVI. References
- (2022) Presc Lett 29(7): 37
- (2023) Presc Lett 30(5): 27-8
- Ables (2003) Am Fam Physician 67(3):547-4 [PubMed]
- Bridges (1995) Br J Hosp Med 54:501-6 [PubMed]
- Cadieux (1998) Am Fam Physician 58(9):2059-62 [PubMed]
- Kovich (2023) Am Fam Physician 107(2): 173-81 [PubMed]
- Little (2009) Am Fam Physician 80(2):167-72 [PubMed]
- Ruhe (2006) J Clin Psychiatry 67:1836-1855 [PubMed]
- Rupke (2006) Am Fam Physician 73(1):83-86 [PubMed]